From: Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
1999 to 2005: Dr. Kazuyo Ichimori | |
• Baseline surveys conducted using ICT | |
• Established a coordinating body and PacELF office and warehouse | |
• Established logistics systems for drugs, diagnostics and data reporting | |
• Regular program managers’ meetings | |
• Development of M&E plan using A (baseline), B (sentinel), C (stop MDA), and D (transmission) surveys; C survey was in all ages and D survey in children | |
• First countries stopped MDA in 2004 | |
• Initiated morbidity surveys | |
• Published PacELF book | |
2006 to 2008: Dr. Corinne Capuano | |
• M&E guideline revision—maintained stop MDA (C) surveys in all ages and transmission surveys in children, with mop up around positive cases | |
• Introduced test and treat strategies in three countries | |
• Improvements to behavior change communication | |
• Morbidity surveys and hydrocoele surgery programs in Fiji | |
• Maintained MDA and post-MDA surveillance | |
2009 to 2011: Dr. Sunghye Kim | |
• Preparation of elimination dossiers | |
• Maintained MDA and post-MDA surveillance | |
2012 to 2017: Dr. Padmasiri Aratchige | |
• Maintained MDA as needed and oversaw transmission assessment surveys | |
• Validation of elimination dossiers approved for Vanuatu, Republic of Marshall Islands, Niue, Cook Is, and Tonga |